Developing a Novel Three-in-One Vaccine for Cat Viruses

Feline herpesvirus-1 (FHV-1) accounts for approximately 50% of all diagnosed viral upper airway infections and is a major cause of eye infections in cats. Current FHV-1 vaccines are a component of core (recommended) vaccinations. While core vaccines provide satisfactory protection against infection for other common cat viruses, including feline calicivirus (FCV) and feline panleukopenia virus (FPV), protection from FHV-1 is limited and short in duration. To address this problem and reduce the need for multiple core vaccinations, researchers will develop a new three-in-one vaccine that is safe and can provide superior protection from FHV-1, in addition to protection from FCV and FPV. The team hopes their new vaccine will provide long-lasting immunity against all three common cat pathogens.